Search results for:
calcitonin
calcitonin
- Provider restrictions: Nephrology, Endocrine, Oncology and Intensivists ONLY
- Patient restrictions: Treatment of symptomatic hypercalcemia for patients who are unresponsive to IV therapy and are not appropriate candidates for pamidronate
- Dose restrictions: Reorder allowable after 24 hours; duration of therapy not to exceed 48 hours for total treatment
Brand names: Calcitonin, Salmon, Miacalcin
Last updated: May. 3, 2018
Footnote A: Restrictions apply to the IV formulation only. There are no restrictions for the nasal spray formulation.
Policies and procedures
Consults, protocols, and therapeutic interchanges
Additional information